| Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q3 24 |
|---|---|---|---|---|---|---|
| End date of the reporting period | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Capitalization, $ | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Capitalization, $ | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Enterprise Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Book Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Shareholders Book Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Current liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Noncurrent liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Total liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Debt | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Cash and cash equivalents | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Net debt | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Assets | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Total ordinary shares | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Ordinary share price | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Ticker | Name | Type | Nominal value | ISIN | Price |
|---|---|---|---|---|---|
| COO:US | Cooper Companies Inc. | Common share | - | US2166484020 | $99.63 |
investor.coopercos.com
investor.coopercos.com
investor.coopercos.com
investor.coopercos.com| Company name | Cooper Companies |
|---|---|
| Tags | #s&p500 index |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies |
| Business address | 6140 STONERIDGE MALL RD STE 590 PLEASANTON CA 94588 9254603600 |
| Mailing address | 6140 STONERIDGE MALL ROAD SUITE 590 PLEASANTON CA 94588 |
| Website | www.coopercos.com |
| Information disclosure | www.sec.gov |